Trial Profile
The Effect of Aliskiren on Proteinuria in Chronic Nondiabetic Kidney Disease: a Double Blind Cross-over Randomized Controlled Trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2015
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Perindopril; Spironolactone
- Indications Hypertension; Kidney disorders
- Focus Therapeutic Use
- Acronyms ALIPRES
- 23 Feb 2012 Results published in the American Journal of Hypertension.
- 19 Oct 2010 New trial record